Polymyositis and Rhabdomyolysis as Paraneoplastic Manifestations of Primary Liver Cancer |
Seo, Yoon-Jong
(Department of Internal Medicine, Sahmyook Medical Center)
Jang, Jae-Hee (Department of Internal Medicine, Sahmyook Medical Center) Park, Ja-Be (Department of Internal Medicine, Sahmyook Medical Center) Joo, Jung-Chul (Department of Internal Medicine, Sahmyook Medical Center) Jung, Jei-Il (Department of Internal Medicine, Sahmyook Medical Center) Jo, Hye-Jae (Department of Pathology, Sahmyook Medical Center) Kwak, Jae-Gyu (Department of Neurology, Sahmyook Medical Center) |
1 | Jeong HJ, Moon WS, Kim SH, et al. A case of combined hepatocellular-chloangiocarcinoma associated with polymyositis and chronic hepatitis B virus infection. Korean J Med 2007;72:79-84. |
2 | Stertz G. Polymyositis. Berl Klin Wochenschr 1916;53:489. |
3 | Callen JP, Hyla JF, Bole GG Jr, Kay DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol 1980;116:295-298. DOI |
4 | Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17. |
5 | Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347. DOI |
6 | Bezechy R. Dermatomyositis. 1st ed. New York: McGraw-Hill, 1986. |
7 | Dawkins RL, Mastaglia FL. Cell-mediated cytotoxicity to muscle in polymyositis: effect of immunosuppression. N Engl J Med 1973;288:434-438. DOI |
8 | Grace JT Jr, DAO TL. Dermatomyositis in cancer: a possible etiological mechanism. Cancer 1959;12:648-650. DOI |
9 | Alexander S, Forman L. Dermatomyositis and carcinoma: a case report and immunological investigation. Br J Dermatol 1968;80:86-89. DOI |
10 | Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology 2000;47:1425-1427. |
11 | Kim PH, Lee HK, Choi DS, et al. Three cases of polymyositis developed associated with chronic liver disease. Korean J Med 1999;56:418-426. |
12 | Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992;326:363-367. DOI |
13 | Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-45. DOI |
14 | Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100. DOI |
15 | Lee HY, Kim ND, Sin GC, Kim WC, Kim SJ, Kim TS. A case dermatomyositis associated with adenocarcinoma of stomach. Korean J Med 1986;31:708-714. |
16 | Yong SJ, Sin GC, Kim WC, Jeong SH. A case of polymyositis associated with epidermoid carcinoma of lung. Korean J Med 1987;32:678-684. |
17 | Joffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-387. DOI |
18 | Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S. Intravenous immunoglobulin therapy for refractory myositis. Intern Med 1996;35:663-667. DOI |
19 | The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. report 7th. Acta Heparol Jpn 1986;27: 1161-1169. DOI |